Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis

Details for Australian Patent Application No. 2010236075 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Hilberg, Frank; Solca, Flavio; Stefanic, Martin Friedrich; Baum, Anke; Munzert, Gerd; Van Meel, Jacobus C.A.

Agent Davies Collison Cave

Pub. Number AU-B-2010236075

Parent 2004233576

Filing date 28 October 2010

Wipo publication date 18 November 2010

Acceptance publication date 4 August 2011

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

18 November 2010 Application Open to Public Inspection

  Published as AU-B-2010236075

18 November 2010 Complete Application Filed

4 August 2011 Application Accepted

  Published as AU-B-2010236075

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236076-Modified Vectors for Organelle Transfection

2010236074-Methods and Materials Using Signaling Probes